Celularity Inc. Increase (Decrease) in Income Taxes Payable
Celularity Inc. (CELU) reported Increase (Decrease) in Income Taxes Payable of -$18.88 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2021-08-19
- Celularity Inc. increase (decrease) in income taxes payable for the quarter ending 2020-12-31 was -$81.70K, a 164.51% decline year-over-year.
- Celularity Inc. increase (decrease) in income taxes payable for the quarter ending 2020-09-30 was -$22.58K.
- Celularity Inc. increase (decrease) in income taxes payable for the quarter ending 2020-06-30 was $42.19K.
- Celularity Inc. increase (decrease) in income taxes payable for the quarter ending 2020-03-31 was $43.21K.
- Celularity Inc. increase (decrease) in income taxes payable for fiscal 2020 was -$18.88K, a 200.00% decline from fiscal 2019.
- Celularity Inc. increase (decrease) in income taxes payable for fiscal 2019 was $18.88K.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$81.70K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | -$104.28K derived: sum of 2 quarters · filed 2021-05-24 | -$62.09K derived: sum of 3 quarters · filed 2021-08-19 | -$18.88K 10-K/A · filed 2021-05-24 |
| 2020-09-30 | -$22.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $19.61K derived: sum of 2 quarters · filed 2021-08-19 | $62.82K 10-Q · filed 2020-11-16 | $189.46K derived: sum of 4 quarters · filed 2021-08-19 |
| 2020-06-30 | $42.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | $85.40K 10-Q · filed 2021-08-19 | $212.04K derived: sum of 3 quarters · filed 2021-08-19 | -$12.61K derived: sum of 4 quarters · filed 2021-08-19 |
| 2020-03-31 | $43.21K 10-Q · filed 2021-05-24 | $169.85K derived: sum of 2 quarters · filed 2021-05-24 | -$54.80K derived: sum of 3 quarters · filed 2021-05-24 | |
| 2019-12-31 | $126.64K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | -$98.01K derived: sum of 2 quarters · filed 2021-05-24 | $18.88K 10-K/A · filed 2021-05-24 | |
| 2019-09-30 | -$224.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$107.76K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $116.89K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |